Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 22, 2022

SELL
$53.92 - $71.7 $602,502 - $801,175
-11,174 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$132.37 - $176.78 $111,190 - $148,495
840 Added 8.13%
11,174 $1.5 Million
Q2 2021

Jul 28, 2021

BUY
$60.88 - $161.91 $629,133 - $1.67 Million
10,334 New
10,334 $1.67 Million

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $632M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.